Mo An-sheng, Lin Hui, Wang Feng, Lin Ying-zhong, Wen Shao-ke, Zhou Yi-fan
Department of Cardiothoracic Surgery, Medical College of Wuhan University, Wuhan 430072, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Apr;36(4):297-9.
To evaluate the clinical outcomes of patients with acute myocardial infarction (AMI) complicating cardiogenic shock underwent various treatments.
From January, 2002 to May, 2007, 47 AMI patients with cardiogenic shock were treated in our department by optimal medication (dopamine, epinephrine, norepinephrine, etc.), intra-aortic balloon pump (IABP), mechanical ventilation when indicated, percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG). Outcome and factors related to mortality for these patients were analyzed in this retrospective study.
Besides optimal medication and IABP in all patients, 31 patients underwent PCI (66.0%), 6 patients received emergency CABG (12.8%). The overall in-hospital mortality rate was 36.2% (17/47), 6 patients (14.9%) died before coronary revascularization and 11 patients (21.3%) died after revascularization. Nine patients died of pump failure and 8 patients died of renal and (or) respiratory failure. Regression analysis showed that acute renal failure (r = 0.734, P = 0.000), acute respiratory failure (r = 0.606, P = 0.000) and diabetes (r = 0.372, P = 0.012) were positively related to in-hospital mortality.
Despite improvements in treatment options for AMI patients complicating cardiogenic shock, in-hospital mortality remained high, especially for patients complicating further with acute renal failure and acute respiratory failure.
评估急性心肌梗死(AMI)合并心源性休克患者接受各种治疗后的临床结局。
2002年1月至2007年5月,我科对47例AMI合并心源性休克患者采用了优化药物治疗(多巴胺、肾上腺素、去甲肾上腺素等)、主动脉内球囊反搏(IABP),必要时进行机械通气、经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)。在这项回顾性研究中分析了这些患者的结局及与死亡率相关的因素。
除了所有患者均接受优化药物治疗和IABP外,31例患者接受了PCI(66.0%),6例患者接受了急诊CABG(12.8%)。总体住院死亡率为36.2%(17/47),6例患者(14.9%)在冠状动脉血运重建前死亡,11例患者(21.3%)在血运重建后死亡。9例患者死于泵衰竭,8例患者死于肾和(或)呼吸衰竭。回归分析显示,急性肾衰竭(r = 0.734,P = 0.000)、急性呼吸衰竭(r = 0.606,P = 0.000)和糖尿病(r = 0.372,P = 0.012)与住院死亡率呈正相关。
尽管AMI合并心源性休克患者的治疗选择有所改善,但住院死亡率仍然很高,尤其是合并急性肾衰竭和急性呼吸衰竭的患者。